Data tools provider CData raised nearly $350M led by Warburg Pincus, a source says at an $800M+ valuation, and says it expects ~$100M in ARR by the end of 2024
Context & Ripple Effects
CData's reported round follows a financing progression from its $20M Series A for data connectivity software in 2020 to a $140M Series B supporting its data-source aggregation platform in 2021. The new valuation and ARR target put a sharper financial marker on that growth arc.
The deal matters because data-access infrastructure sits upstream of analytics and business software: investor confidence in CData is therefore a signal about the value assigned to recurring-revenue connectivity platforms, not just a single vendor.
First-order effects
- CData gains a substantially larger capital base, with Warburg Pincus reportedly taking the lead, while its expected roughly $100M ARR becomes the near-term operating benchmark for the company.
- The reported $800M-plus valuation gives CData a new reference point for employees, customers, and prospective investors assessing the company’s scale and execution.
Second-order effects
- Other data-connectivity and analytics-tool vendors will face a more concrete private-market benchmark when raising capital or positioning their growth profiles to buyers.
- The transaction provides a comparison point alongside dbt Labs' $222M Series D, reinforcing investor attention on software that helps businesses make operational data usable across systems.
Third-order effects
- If similar financings continue, the data-infrastructure market may increasingly reward platforms that pair broad integrations with measurable recurring revenue, favoring scaled vendors over narrower point solutions.
- That shift could make capital efficiency and durable retention more important in future funding rounds, though one reported transaction alone does not establish a sector-wide repricing.
The trend: Enterprise data infrastructure is being valued increasingly through the combination of integration breadth and recurring-revenue scale.